Report Detail
Global Cell and Gene Therapy CRO Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4757337 |
- 13 October, 2026 |
- Global |
- 111 Pages |
- GIR |
- Service & Software
According to our (Global Info Research) latest study, the global Cell and Gene Therapy CRO Service market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Cell and Gene Therapy CRO (Contract Research Organization) Service refers to a service offered by a third-party organization that specializes in providing research and development support to companies involved in cell and gene therapy. This service may include cell line development, preclinical testing, clinical trial management, regulatory services, and product manufacturing to facilitate the development and commercialization of cell and gene therapies.
This report is a detailed and comprehensive analysis for global Cell and Gene Therapy CRO Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cell and Gene Therapy CRO Service market size and forecasts, in consumption value ($ Million), 2021-2032
Global Cell and Gene Therapy CRO Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Cell and Gene Therapy CRO Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Cell and Gene Therapy CRO Service market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell and Gene Therapy CRO Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell and Gene Therapy CRO Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PPD, Medpace, Labcorp, Veristat, Charles River Laboratories, Premier Research, Catalent, IQVIA, Vial, Noble Life Sciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Cell and Gene Therapy CRO Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Preclinical CRO
Clinical Stage CRO
Others
Market segment by Application
Hospital
Research Institute
Others
Market segment by players, this report covers
PPD
Medpace
Labcorp
Veristat
Charles River Laboratories
Premier Research
Catalent
IQVIA
Vial
Noble Life Sciences
Ergomed
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell and Gene Therapy CRO Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell and Gene Therapy CRO Service, with revenue, gross margin, and global market share of Cell and Gene Therapy CRO Service from 2021 to 2026.
Chapter 3, the Cell and Gene Therapy CRO Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Cell and Gene Therapy CRO Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell and Gene Therapy CRO Service.
Chapter 13, to describe Cell and Gene Therapy CRO Service research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Cell and Gene Therapy CRO Service by Type
- 1.3.1 Overview: Global Cell and Gene Therapy CRO Service Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Cell and Gene Therapy CRO Service Consumption Value Market Share by Type in 2025
- 1.3.3 Preclinical CRO
- 1.3.4 Clinical Stage CRO
- 1.3.5 Others
- 1.4 Global Cell and Gene Therapy CRO Service Market by Application
- 1.4.1 Overview: Global Cell and Gene Therapy CRO Service Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital
- 1.4.3 Research Institute
- 1.4.4 Others
- 1.5 Global Cell and Gene Therapy CRO Service Market Size & Forecast
- 1.6 Global Cell and Gene Therapy CRO Service Market Size and Forecast by Region
- 1.6.1 Global Cell and Gene Therapy CRO Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global Cell and Gene Therapy CRO Service Market Size by Region, (2021-2032)
- 1.6.3 North America Cell and Gene Therapy CRO Service Market Size and Prospect (2021-2032)
- 1.6.4 Europe Cell and Gene Therapy CRO Service Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific Cell and Gene Therapy CRO Service Market Size and Prospect (2021-2032)
- 1.6.6 South America Cell and Gene Therapy CRO Service Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa Cell and Gene Therapy CRO Service Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 PPD
- 2.1.1 PPD Details
- 2.1.2 PPD Major Business
- 2.1.3 PPD Cell and Gene Therapy CRO Service Product and Solutions
- 2.1.4 PPD Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 PPD Recent Developments and Future Plans
- 2.2 Medpace
- 2.2.1 Medpace Details
- 2.2.2 Medpace Major Business
- 2.2.3 Medpace Cell and Gene Therapy CRO Service Product and Solutions
- 2.2.4 Medpace Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Medpace Recent Developments and Future Plans
- 2.3 Labcorp
- 2.3.1 Labcorp Details
- 2.3.2 Labcorp Major Business
- 2.3.3 Labcorp Cell and Gene Therapy CRO Service Product and Solutions
- 2.3.4 Labcorp Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Labcorp Recent Developments and Future Plans
- 2.4 Veristat
- 2.4.1 Veristat Details
- 2.4.2 Veristat Major Business
- 2.4.3 Veristat Cell and Gene Therapy CRO Service Product and Solutions
- 2.4.4 Veristat Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Veristat Recent Developments and Future Plans
- 2.5 Charles River Laboratories
- 2.5.1 Charles River Laboratories Details
- 2.5.2 Charles River Laboratories Major Business
- 2.5.3 Charles River Laboratories Cell and Gene Therapy CRO Service Product and Solutions
- 2.5.4 Charles River Laboratories Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Charles River Laboratories Recent Developments and Future Plans
- 2.6 Premier Research
- 2.6.1 Premier Research Details
- 2.6.2 Premier Research Major Business
- 2.6.3 Premier Research Cell and Gene Therapy CRO Service Product and Solutions
- 2.6.4 Premier Research Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Premier Research Recent Developments and Future Plans
- 2.7 Catalent
- 2.7.1 Catalent Details
- 2.7.2 Catalent Major Business
- 2.7.3 Catalent Cell and Gene Therapy CRO Service Product and Solutions
- 2.7.4 Catalent Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Catalent Recent Developments and Future Plans
- 2.8 IQVIA
- 2.8.1 IQVIA Details
- 2.8.2 IQVIA Major Business
- 2.8.3 IQVIA Cell and Gene Therapy CRO Service Product and Solutions
- 2.8.4 IQVIA Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 IQVIA Recent Developments and Future Plans
- 2.9 Vial
- 2.9.1 Vial Details
- 2.9.2 Vial Major Business
- 2.9.3 Vial Cell and Gene Therapy CRO Service Product and Solutions
- 2.9.4 Vial Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Vial Recent Developments and Future Plans
- 2.10 Noble Life Sciences
- 2.10.1 Noble Life Sciences Details
- 2.10.2 Noble Life Sciences Major Business
- 2.10.3 Noble Life Sciences Cell and Gene Therapy CRO Service Product and Solutions
- 2.10.4 Noble Life Sciences Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Noble Life Sciences Recent Developments and Future Plans
- 2.11 Ergomed
- 2.11.1 Ergomed Details
- 2.11.2 Ergomed Major Business
- 2.11.3 Ergomed Cell and Gene Therapy CRO Service Product and Solutions
- 2.11.4 Ergomed Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Ergomed Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Cell and Gene Therapy CRO Service Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Cell and Gene Therapy CRO Service by Company Revenue
- 3.2.2 Top 3 Cell and Gene Therapy CRO Service Players Market Share in 2025
- 3.2.3 Top 6 Cell and Gene Therapy CRO Service Players Market Share in 2025
- 3.3 Cell and Gene Therapy CRO Service Market: Overall Company Footprint Analysis
- 3.3.1 Cell and Gene Therapy CRO Service Market: Region Footprint
- 3.3.2 Cell and Gene Therapy CRO Service Market: Company Product Type Footprint
- 3.3.3 Cell and Gene Therapy CRO Service Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Cell and Gene Therapy CRO Service Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Cell and Gene Therapy CRO Service Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Cell and Gene Therapy CRO Service Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Cell and Gene Therapy CRO Service Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Cell and Gene Therapy CRO Service Consumption Value by Type (2021-2032)
- 6.2 North America Cell and Gene Therapy CRO Service Market Size by Application (2021-2032)
- 6.3 North America Cell and Gene Therapy CRO Service Market Size by Country
- 6.3.1 North America Cell and Gene Therapy CRO Service Consumption Value by Country (2021-2032)
- 6.3.2 United States Cell and Gene Therapy CRO Service Market Size and Forecast (2021-2032)
- 6.3.3 Canada Cell and Gene Therapy CRO Service Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Cell and Gene Therapy CRO Service Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Cell and Gene Therapy CRO Service Consumption Value by Type (2021-2032)
- 7.2 Europe Cell and Gene Therapy CRO Service Consumption Value by Application (2021-2032)
- 7.3 Europe Cell and Gene Therapy CRO Service Market Size by Country
- 7.3.1 Europe Cell and Gene Therapy CRO Service Consumption Value by Country (2021-2032)
- 7.3.2 Germany Cell and Gene Therapy CRO Service Market Size and Forecast (2021-2032)
- 7.3.3 France Cell and Gene Therapy CRO Service Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Cell and Gene Therapy CRO Service Market Size and Forecast (2021-2032)
- 7.3.5 Russia Cell and Gene Therapy CRO Service Market Size and Forecast (2021-2032)
- 7.3.6 Italy Cell and Gene Therapy CRO Service Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Cell and Gene Therapy CRO Service Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Cell and Gene Therapy CRO Service Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Cell and Gene Therapy CRO Service Market Size by Region
- 8.3.1 Asia-Pacific Cell and Gene Therapy CRO Service Consumption Value by Region (2021-2032)
- 8.3.2 China Cell and Gene Therapy CRO Service Market Size and Forecast (2021-2032)
- 8.3.3 Japan Cell and Gene Therapy CRO Service Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Cell and Gene Therapy CRO Service Market Size and Forecast (2021-2032)
- 8.3.5 India Cell and Gene Therapy CRO Service Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Cell and Gene Therapy CRO Service Market Size and Forecast (2021-2032)
- 8.3.7 Australia Cell and Gene Therapy CRO Service Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Cell and Gene Therapy CRO Service Consumption Value by Type (2021-2032)
- 9.2 South America Cell and Gene Therapy CRO Service Consumption Value by Application (2021-2032)
- 9.3 South America Cell and Gene Therapy CRO Service Market Size by Country
- 9.3.1 South America Cell and Gene Therapy CRO Service Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Cell and Gene Therapy CRO Service Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Cell and Gene Therapy CRO Service Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Cell and Gene Therapy CRO Service Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Cell and Gene Therapy CRO Service Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Cell and Gene Therapy CRO Service Market Size by Country
- 10.3.1 Middle East & Africa Cell and Gene Therapy CRO Service Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Cell and Gene Therapy CRO Service Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Cell and Gene Therapy CRO Service Market Size and Forecast (2021-2032)
- 10.3.4 UAE Cell and Gene Therapy CRO Service Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Cell and Gene Therapy CRO Service Market Drivers
- 11.2 Cell and Gene Therapy CRO Service Market Restraints
- 11.3 Cell and Gene Therapy CRO Service Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Cell and Gene Therapy CRO Service Industry Chain
- 12.2 Cell and Gene Therapy CRO Service Upstream Analysis
- 12.3 Cell and Gene Therapy CRO Service Midstream Analysis
- 12.4 Cell and Gene Therapy CRO Service Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Cell and Gene Therapy CRO Service. Industry analysis & Market Report on Cell and Gene Therapy CRO Service is a syndicated market report, published as Global Cell and Gene Therapy CRO Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Cell and Gene Therapy CRO Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
